Writing about a category that will not sit still
Longer pieces on the botanical trade — how the regulation actually works, what changed and why, and the practical craft of building products in a market that keeps resetting. Written for people who make things, not for search engines.
The kratom industry in 2026: what actually changed
Three years of regulatory pressure compressed into one honest summary — what happened to which compound, what it did to the shelf, and what the pattern predicts.
Read — 9 min →RegulatoryHow DEA scheduling actually works
What a notice of intent is, how temporary scheduling differs from permanent, why states often move first, and what any of it means for a brand holding inventory.
Read — 8 min →QualityHow to read a certificate of analysis
Most buyers in this category cannot tell a good certificate from a decorative one. Here is what to look for, what to be suspicious of, and the questions that get honest answers.
Read — 7 min →CategoryWhere botanicals fit in the alcohol-alternative boom
The fastest-growing shelf in beverage is being built by brands from outside beverage. What the category actually rewards, and where kratom-free botanicals have an opening.
Read — 7 min →StrategyWhy every product on the kratom shelf looks the same
It is not laziness. It is a supply-side constraint that has been tightening for three years — and understanding it is how you get out from under it.
Read — 6 min →What we write about, and what we do not
We publish when we have something specific to say — a regulatory action worth explaining, a piece of craft worth documenting, or a bad idea worth arguing against.
- Regulatory mechanics, explained properly. Most coverage of this category reports outcomes without explaining the machinery, which leaves brands unable to predict anything.
- Formulation craft — the practical decisions that separate a product that works from one that ships.
- Category analysis where we have a genuine view, including about our own product's limits.
- Never health claims, never comparisons to controlled substances, and never a piece written to hit a keyword rather than to say something. Our editorial standards.
Something you want explained?
If there is a piece of this category you cannot get a straight answer about, tell us. Some of what is here started as a question from a customer that deserved more than an email.